×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| THEMIS MEDICARE LTD. | 987.54 | -153.74 | 975.78 | -1.67 | 1,026 | 34.4 |
| Kwality Pharmaceuticals Limite | NA | NA | NA | NA | 982 | 22.6 |
| Bharat Parenterals Limited | NA | NA | NA | NA | 941 | 38.8 |
Themis Medicare Ltd., with Security Code 530199, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 80.1 | 96.6 | 104.8 | 82.5 | 97.8 | 106.1 | 99.6 | 93.8 | 71.7 | 97.6 |
| Expenses | 69.6 | 74.9 | 92.4 | 74.4 | 88.5 | 76.8 | 82.6 | 85.3 | 77.4 | 107.7 |
| Operating Profit | 10.5 | 21.7 | 12.4 | 8.1 | 9.3 | 29.2 | 17.0 | 8.5 | -5.7 | -10.1 |
| OPM % | 13.09% | 22.5% | 11.84% | 9.78% | 9.52% | 27.57% | 17.09% | 9.09% | -7.97% | -10.33% |
| Other Income | 2.9 | 0.7 | 2.4 | 0.6 | 1.1 | 0.7 | 0.8 | 1.0 | 1.6 | -0.1 |
| Interest | 2.7 | 2.5 | 2.0 | 2.7 | 2.2 | 1.4 | 1.6 | 2.8 | 2.5 | 2.5 |
| Depreciation | 2.8 | 3.0 | 3.1 | 3.1 | 3.1 | 1.0 | 1.1 | 2.5 | 2.5 | 2.6 |
| Profit before tax | 7.9 | 16.9 | 9.7 | 2.9 | 5.2 | 27.5 | 15.1 | 4.2 | -9.1 | -13.9 |
| Tax % | -23.8% | -25.6% | -27.1% | -29.8% | -40.5% | -26.2% | -26.1% | -27% | 0% | -1% |
| Net Profit | 6.0 | 12.6 | 7.1 | 2.0 | 3.1 | 18.7 | 9.9 | 3.1 | -7.7 | -15.4 |
| EPS in Rs | 6.55 | 13.62 | 7.7 | 0.22 | 0.34 | 2.03 | 1.07 | 0.33 | 0 | -1.67 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 88.8 | 80.1 | 96.6 | 104.8 | 82.5 | 97.8 | 123.0 | 117.0 | 93.8 | 71.7 |
| Expenses | 73.5 | 69.6 | 74.9 | 92.4 | 74.5 | 88.5 | 93.8 | 99.9 | 87.8 | 79.3 |
| Operating Profit | 15.3 | 10.5 | 21.7 | 12.4 | 8.1 | 9.3 | 29.2 | 17.1 | 6.0 | -7.6 |
| OPM % | 17.2% | 13.08% | 22.5% | 11.84% | 9.77% | 9.5% | 23.72% | 14.64% | 6.36% | -10.64% |
| Other Income | 5.9 | 2.9 | 0.7 | 2.4 | 0.6 | 1.1 | 1.0 | 1.1 | 1.0 | 1.6 |
| Interest | 2.2 | 2.7 | 2.5 | 2.0 | 2.7 | 2.2 | 2.4 | 2.4 | 2.8 | 2.5 |
| Depreciation | 2.7 | 2.8 | 3.0 | 3.1 | 3.1 | 3.1 | 2.4 | 2.5 | 2.5 | 2.5 |
| Profit before tax | 16.3 | 7.9 | 16.9 | 9.7 | 2.8 | 5.2 | 25.4 | 13.4 | 1.7 | -11.1 |
| Tax % | -25.7% | -23.8% | -25.6% | -27.1% | -29.9% | -40.7% | -26.3% | -26.2% | -27% | 0% |
| Net Profit | 13.3 | 8.4 | 18.2 | 11.3 | 7.4 | 6.6 | 24.7 | 14.3 | 0.5 | -9.7 |
| EPS in Rs | 14.44 | 9.12 | 19.73 | 12.28 | 0.8 | 0.72 | 2.68 | 1.55 | 0.06 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 1% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 9% |
| 3 Years: | -27% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 35% |
| 3 Years: | 19% |
| 1 Year: | -34% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 15% |
| 3 Years: | 1% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 4% |
| 3 Years: | -25% |
| TTM: | -29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 35% |
| 3 Years: | 19% |
| 1 Year: | -34% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|